Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Lupus Erythematosus

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

Arthritis Res Ther

Kojima K, Ichinose K, Umeda M, Shimizu T, Sato S, Suzuki T, Nakashima Y, Okada A, Horai Y, Fujikawa K, Aramaki T, Miyashita T, Furuyama M, Matsuoka N, Kawakami A

doi: 10.1186/s13075-025-03581-0

Systemic Lupus Erythematosus

Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus

Clin Immunol

Natoli V, Charras A, Hasoon MSR, Jorgensen AL, Smith EMD, Gutiérrez EC, Beresford MW, Hedrich CM, UK JSLE Cohort Study Group

doi: 10.1016/j.clim.2025.110540

Systemic Lupus Erythematosus

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Semin Arthritis Rheum

Ibarguengoitia-Barrena O, Riancho-Zarrabeitia L, Plaza Z, Rúa-Figueroa Í, Roberts K, Martínez-Taboada V, Menor-Almagro R, Serrano-Benavente B, Rubio-Muñoz P, Galindo-Izquierdo M, Fernández-Nebro A, Ruiz-Lucea ME, Calvo-Alén J, Tomero-Muriel EG, Uriarte-Isacelaya E, Pecondon-Españo A, Freire M, García-Fernández J, Expósito L, Ibañez-Barceló M, Aurrecoechea E, Montilla C, Rosas-Gómez de Salazar J, García-Villanueva MJ, Caño-Alameda R, Toyos-Sáenz de Miera FJ, Nóvoa-Medina FJ, Moriano-Morales C, Bonilla G, Narváez FJ, Andréu JL, Arévalo-Salaet M, Horcada L, Cobo T, Lozano-Rivas N, Bohorquez C, Iñíguez-Ubiaga CL, Salgado-Perez E, Torrente-Segarra V, Salman Monte TC, Oller JE, Pego-Reigosa JM, RELESSER research group

doi: 10.1016/j.semarthrit.2025.152819

Systemic Lupus Erythematosus

Factors associated with delay in the diagnosis and treatment of systemic lupus erythematosus in adult patients: a systematic review

Rheumatology (Oxford)

Ramírez-Flores MF, Hernandez-Garduno A, Quintana R, Fuentes-Silva Y, Nieto R, Cano-Gámez T, Ferreyra L, Ceballos MF, Gastelum-Strozzi A, Pons-Estel BA, Pons-Estel G, Peláez-Ballestas I

doi: 10.1093/rheumatology/keaf384

Systemic Lupus Erythematosus

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Ann Rheum Dis

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A, PRECISESADS Clinical Consortium, Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I

doi: 10.1016/j.ard.2025.06.2132

Systemic Lupus Erythematosus

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus

Arthritis Care Res (Hoboken)

Sammaritano LR, Askanase A, Bermas BL, Dall'Era M, Duarte-García A, Hiraki LT, Son MBF, Werth VP, Aranow C, Barnado A, Broder A, Brunner HI, Chong BF, Chowdhary VR, Hersh AO, Izmirly PM, Jules M, Kalunian K, Kamen D, Rubinstein TB, Smith BJ, Smith NM, Thomas A, Timlin H, Wallace DJ, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Gomes LLA, Cuéllar-Gutiérrez MC, Iyer P, Johannemann AS, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Legge A, Liang KP, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Turner AS, Mustafa RA

doi: 10.1002/acr.25690

Systemic Lupus Erythematosus

Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

Rheumatology (Oxford)

Dominicus A, Mageau A, Nguyen NV, Blomkvist Sporre K, Svenungsson E, Arkema EV

doi: 10.1093/rheumatology/keaf192

Systemic Lupus Erythematosus

Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 U.S. rheumatology clinics

Rheumatology (Oxford)

Singh JA, Hearld LR, Eisen S, Chatham WW, Narain S, Annapureddy N, Kamen DL, Trotter K, Majithia V, Lee Ching C, Aouhab Z, Venuturupalli S, Wallace DJ, Ramsey-Goldman R, Kim A, McMahon M, Sam Lim S, Bhairavarasu K, Meara A, Kalunian K, Beasley M, Implementing DEcision-Aid for Lupus in clinics (IDEAL) Consortium

doi: 10.1093/rheumatology/keaf205

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Factors associated with delay in the diagnosis and treatment of systemic lupus erythematosus in adult patients: a systematic review

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus

Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 U.S. rheumatology clinics